Cargando…
Use of Methylene Blue in the Treatment of Refractory Vasodilatory Shock After Cardiac Assist Device Implantation: Report of Four Consecutive Cases
Vasodilatory shock frequently occurs after cardiac surgery, particularly after cardiac assist device implantation. This complication is often associated with high mortality, especially if refractory to conventional vasoconstrictor treatment. Methylene blue, a guanylate cyclase inhibitor, has been su...
Autores principales: | Michel, Sebastian, Weis, Florian, Sodian, R, Beiras-Fernandez, Andres, Bigdeli, Amir K, Kaczmarek, Ingo, Bruegger, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376881/ https://www.ncbi.nlm.nih.gov/pubmed/22719809 http://dx.doi.org/10.4021/jocmr804w |
Ejemplares similares
-
Methylene blue for vasodilatory shock in the intensive care unit: a retrospective, observational study
por: Naoum, Emily E., et al.
Publicado: (2022) -
Methylene Blue in Refractory Shock
por: Chalise, Som N, et al.
Publicado: (2022) -
Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis
por: Zhao, Cong-Cong, et al.
Publicado: (2022) -
METHYLENE BLUE IN REFRACTORY SEPTIC SHOCK
por: Eliliwi, Mouhanned, et al.
Publicado: (2020) -
Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease
por: Michel, Sebastian, et al.
Publicado: (2012)